Application of a Clinical Decision Support System to Reduce Mechanical Ventilation Duration After Cardiac Surgery

Congenital Heart Disease Clinical Trial

Official title:

Application of a Clinical Decision Support System to Reduce Mechanical Ventilation Duration After Cardiac Surgery

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05687292
• Other study ID #: P00044253
• Status: Not yet recruiting
• Start date: September 2024
• Est. completion date: March 2026

Study information

• Verified date: April 2024
• Source: Boston Children's Hospital
• Contact: Daniel L Hames, MD
• Phone: 6173554023
• Email: daniel.hames[@]cardio.chboston.org
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The goal of this study is to evaluate the impact of a clinical decision support system (CDSS) in children receiving mechanical ventilation (MV) after surgery for congenital heart disease (CHD). The main question it aims to answer is: -What is the impact of a CDSS designed to facilitate weaning and discontinuation of MV on the duration of MV in post-operative congenital cardiac surgery patients? Participants will be identified as eligible to initiate weaning from mechanical ventilation. Providers will decide whether or not to initiate weaning based on recommendations provided by the CDSS. Researchers will compare patients exposed to the CDSS with a historical cohort to see if the CDSS facilitated a decrease in MV duration.

Description:

Prolonged mechanical ventilation (MV) in children with congenital heart disease (CHD) is associated with morbidity and mortality. There is no standard approach to weaning MV in CHD patients. Similarly, extubation failure is associated with morbidity and mortality, and there is no existing method for predicting extubation success in CHD patients. The overarching aim of this study is to use a novel clinical decision support system (CDSS) informed by continuous data streams and risk analytics algorithms to facilitate shorter MV duration. The CDSS will be built into the T3 Visualization Platform (T3). T3 continuously tracks all inputs from a patient's existing physiologic monitors, ventilator, and laboratory values from the electronic medical record. T3 then graphically displays the data on a single bedside computer/monitor that is updated every 5 seconds. The platform includes three FDA 510(k)-cleared predictive analytics algorithms for estimating the risk of low cardiac output (IDO2), inadequate ventilation (IVCO2), and acidosis (IPH). The investigators for this study have previously evaluated IDO2 and IVCO2 in a retrospective cohort of children receiving MV for greater than or equal to 48 hours following cardiac surgery. This study identified that patients with a low IDO2 and IVCO2 had a higher probability of remaining extubated without the need for reintubation or unplanned use of noninvasive ventilation in the 48 hours following extubation. The CDSS will be designed to prompt discussion around timing of ventilator weaning, extubation readiness assessments, and extubation. Recommendations will be informed by the continuous monitoring of a patient and based on trends in vital signs and the risk analytics algorithms. This study will be a single center, nonrandomized before and after study with additional quasi-experimental design component using interrupted time-series analysis (with retrospective evaluation of pre-intervention and prospective data collection post-intervention).

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 330
• Est. completion date: March 2026
• Est. primary completion date: March 2026
• Accepts healthy volunteers: No
• Gender: All
• Age group: 1 Day to 12 Years

Eligibility

Inclusion Criteria:

• Children < 12 years old
• Post-cardiac surgery
• Receiving mechanical ventilation for = 48 hours in the Cardiac Intensive Care Unit at Boston Children's Hospital following surgery

Exclusion Criteria:

• Premature infants (<37 weeks' gestation)
• Weight < 2kg
• Baseline ventilator (via tracheostomy) or noninvasive positive pressure dependence

Related Conditions & MeSH terms

• Congenital Heart Disease
• Heart Defects, Congenital
• Heart Diseases

Intervention

Device:
• Clinical decision support system (CDSS) for ventilator weaning
A clinical decision support system (CDSS) will be integrated into a software program (the T3 platform) that is present on all patient bedside computers. The T3 platform is a tool that compiles data from a patient's existing physiologic monitors, ventilator, and laboratory results and graphically displays them on a bedside monitor. The CDSS will be active on all patients receiving mechanical ventilation, but primary use and evaluation will focus on patients meeting study criteria. Twice daily (on morning rounds and evening rounds), patients will be screened for eligibility. During each rounds, teams will review the CDSS and associated risk analytics data used to inform the associated recommendations for ventilator weaning, extubation readiness assessment, and extubation. The clinical team will consider the CDSS in decision making around ventilator weans. If the decision is made not to follow the CDSS recommendations, the clinician will complete a brief survey with rationale.

Locations

Country	Name	City	State
United States	Boston Children's Hospital	Boston	Massachusetts

Sponsors (2)

Lead Sponsor	Collaborator
Boston Children's Hospital	The Brett Boyer Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Cardiac intensive care unit length of stay	Measured in days	From date of surgery until the date of initial discharge from the cardiac intensive care unit, assessed up to 52 weeks
Primary	Duration of Mechanical Ventilation	Measured in days; Obtained from date/time of initial extubation minus date/time of admission from surgery, divided by 24 to give an exact determination of days	Up to 28 days after surgery
Secondary	Unplanned extubation	Unplanned extubation during CDSS activation; Occurring between return from surgery and initial planned extubation	From date of surgery until date of first documented extubation, assessed up to 28 days
Secondary	Unplanned use of noninvasive ventilation	Patient extubated to room air requiring escalation to positive pressure ventilation	Within 48 hours of extubation
Secondary	Unplanned reintubation	Patient requires unplanned replacement of breathing tube	Within 48 hours of extubation
Secondary	Adherence rate by clinical team to CDSS recommendations	Clinical team follows recommendations provided by the CDSS for ventilator weaning, extubation readiness test performance, and extubation	From date of CDSS initiation until date of first documented extubation, assessed up to 28 days